Skip to content
Home/Companies/Pharma/Interor
Interor

Interor

Pharma·France·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Interor?

Interor is a French Pharma company, currently owned by Turenne Groupe since 2020.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Turenne Groupe
Investor
Turenne Groupe
Capital Santé 2 · 2020 · Growth

Key facts

HQFrance
SectorPharma
Websitewww.interor.com

More from Capital Santé 2

Other portfolio companies in the same fund.

Le Petit Souk
Active
ConsumerFrance· 2026
M&C3i
Active
SoftwareFrance· 2026
Agrotech
Active
ConstructionFrance· 2025
Anothercorp.
Active
ConsumerFrance· 2025
Groupe Colibri – Promesse de Fleurs
Active
ConsumerFrance· 2025
Kimialys
Active
IndustrialsFrance· 2025

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Interor?

Interor is currently owned by Turenne Groupe, through Capital Santé 2, since 2020.

When did Turenne Groupe acquire Interor?

Turenne Groupe acquired Interor in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue